DH20931
DH20931 is a ceramide synthase 2 (CerS2) activator. DH20931 inhibits growth of cancer cells by inducing lipotoxic endoplasmic reticulum (ER) stress. DH20931 shows synergistic anti-tumor efficacy with Doxorubicin (HY-15142A). DH20931 can be used for the research of breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 1629992-28-4
- Formula: C21H21ClN2O2
- Molecular Weight:368.86
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
|
Caspase 3 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BT-474 | IC50 |
0.3 μM
Compound: 1c, DH20931
|
Cytotoxicity against human BT474 cells assessed as growth inhibition after 48 hrs by methylene blue staining-based assay
Cytotoxicity against human BT474 cells assessed as growth inhibition after 48 hrs by methylene blue staining-based assay
|
[PMID: 25240616] |
DH20931 potently inhibits the growth of MDA-MB231, MDA-MB468, BT474, MCF7, and T47D cancer cells with IC50 values of 3.9, 1.8, 0.3, 1.3 and 1.0 μM[1].
DH20931 significantly reduces the required IC50 of Doxorubicin (HY-15142A) by 3-8-fold, resulting in hyper-activation of the UPR, maximized ATF4/CHOP/PUMA expression, and a marked increase in cleaved caspase-3[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1629992-28-4
-
Molecular Weight 368.86
-
Formula C21H21ClN2O2
-
SMILES
COC1=CC=C2C3=C4C5=C(CCN4C=[N+]3CCC2=C1)C=C(C=C5)OC.[Cl-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)